Clinical Trials Logo

Persistent Disease clinical trials

View clinical trials related to Persistent Disease.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01267253 Completed - Clinical trials for Cervical Adenocarcinoma

Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer

Start date: April 4, 2011
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well brivanib alaninate works in treating patients with cervical cancer that has come back. Brivanib alaninate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth or by blocking blood flow to the tumor.